CDC Announces IV Artesunate as New First-Line Treatment for Severe Malaria - Contagionlive.com

-
A change in protocol for the treatment of severe malaria has been announced by the US Centers for Disease Control and Prevention (CDC). The agency announced today that as of April 1, 2019, artesunate will become the first-line treatment for severe malaria in the United States.

The new guidance was based upon the decision by the manufacturer of the antimalarial drug quindine, the only US Food and Drug Administration (FDA) approved intravenous (IV) antimalarial, to discontinue production of the drug.

IV artesunate is the first-line World Health Organization-recommended treatment for severe malaria. According to the CDC, clinical studies have shown that IV artesunate is safe and well-tolerated. Additionally, it is reported that the drug can be administered to infants and children, as well as pregnant women during the second and third trimesters and during lactation. The announcement further indicates that “in the first trimester of pregnancy, the benefits of IV artesunate treatment outweigh the risk of death and poor outcomes due to severe malaria.”

Malaria continues to remain a major source of illness and death across the globe, with an estimated 219 million cases, resulting in 435,000 deaths in 2017. In the US, an average of 1700 travelers return to the US with malaria with growing incidence rates. The CDC estimates that approximately 300 Americans return from abroad with severe malaria.

Despite the updated recommendations, artesunate is not FDA approved or commercially available in the United States; it is unknown when the drug will be approved, as a new drug application must be submitted. However, the CDC will make IV artesunate available through an expanded use investigational new drug protocol. The development of artesunate in the United States has been a collaboration between the Walter Reed Army Institute of Research and the US Army Medical Material Development Activity.

Clinicians who are treating a patient with severe malaria are required to call the CDC’s Malaria Hotline to obtain the drug. Following a consultation with a CDC expert who will determine if artesunate is needed, the drug will be provided for free to the CDC quarantine with the closest proximity to the health system where the clinician is operating.

The CDC will stock artesunate at 10 of the 20 US quarantine stations and anticipates that there will be a sufficient supply of the drug available for the treatment of all cases of severe malaria in the US.

To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


https://ift.tt/2HNc0U4

Comments

Post a Comment

Popular posts from this blog

Manual on meat inspection for developing countries

-
Image
sinusitis treatment :: Article Creator My 'sinus Infection' Turned Out To Be A One In A Million Nasal Cancer At Just 28 - And Doctors Had To Cut My Eye Out To Save Me By Emily Joshu Health Reporter For Dailymail.Com Published: 06:33 EDT, 20 April 2024Updated: 06:35 EDT, 20 April 2024 A 28 year-old California woman has described the shock of being diagnosed with a deadly sinus cancer that affects fewer than one in a million people - and led to the removal of her right eye. The 'golf ball-sized tumor', which had spread throughout her face, was first mistaken for a sinus infection by the woman's doctors.  Annika, who posts about her condition on TikTok, woke up one morning in 2023 and noticed that the inner corner of her right eye was sore.  While she at first thought nothing of it, by the time the evening rolled around, 'my face started to really, really hurt on the right side,' she said in a video.  The next day, her
Read more

Rash behind ear: Causes, other symptoms, and treatment - Medical News Today

-
Image
A rash behind the ear may occur due to a variety of different medical conditions. Certain viral infections and autoimmune diseases may cause a rash behind the ear in both children and adults. While some causes, such as contact dermatitis, are not concerning, other causes, including rubella, may be more serious. In this article, we look at some of the causes of a rash behind the ear, as well as the other symptoms that they may produce and how to treat them. Contact dermatitis is an allergic reaction to a particular substance. If an allergy-inducing substance comes into contact with the skin behind the ear, a rash can form. Allergens that may cause contact dermatitis behind the ears include: shampoos soaps other hair care products For example, hair dye products contain an ingredient called paraphenylenediamine (PPD), which is a common contact allergen. Symptoms Contact dermatitis causes itchiness, dryness, and flaking of the skin that came into contact with the allergen. Diagnosis A doc
Read more

Having This One Particular Blood Type Can Help Protect You From Severe Malaria - ScienceAlert

-
Image
Nearly  half the world's population is at risk of malaria, one of the most deadly diseases known to humankind. Each year it claims  over 400,000 lives, most of whom are children younger than age five. While it's possible to vaccinate against malaria, virtually all of these cases are in the African region, where protection is often nothing more than a roll of the dice. Now, a recent  analysis  of 23 papers suggests those with blood type O have the genetic odds stacked in their favour. In sub-Saharan Africa, where severe malaria - caused by the  Plasmodium falciparum  parasite  - is endemic, there are far more individuals with blood type O than anywhere in Europe or the US. In Nigeria alone, where 97 percent of the country is at risk of malaria, more than half the population belongs to this blood group. In Ethiopia and many others, the numbers are similar. Rather than a coincidence, co-author and epidemiologist Abraham Degarege Mengist from Robert Stempel College of Publi
Read more